Ozempic vs. Rybelsus | Better You Rx

Ozempic vs. Rybelsus

You may have heard about Ozempic and Rybelsus if you have Type 2 Diabetes and are having trouble controlling your blood sugar levels. Both treatments, which are non-insulin pharmaceuticals with the active component semaglutide, are well-known for their ability to significantly reduce hemoglobin A1C levels.

What makes a difference, then? And which is the wiser decision?

The solution is simple for individuals who dislike injections: Ozempic is an injectable medication, but Rybelsus is an oral prescription that comes in tablet form. Having said that, the two medications also differ in other ways.

We’ll examine Rybelsus and Ozempic in-depth in this essay, focusing on the differences between them. The following details are supplied solely for your information. To find out if a prescription for Rybelsus or Ozempic could be the best option for your unique circumstances, speak with your doctor directly.

Ozempic: What Is It?

In 2017, the FDA approved the use of the brand-name prescription drug Ozempic (semaglutide) for treating Type 2 Diabetes and associated cardiovascular disease in persons over the age of 18. Novo Nordisk is the manufacturer of it.


Ozempic is a once-weekly medicine that is injected subcutaneously into the upper arm, thigh, or abdomen. It comes in pre-filled, single-patient-use injection pens, needs to be kept in the fridge before use, and should be disposed of properly once it has reached its expiration date.


Ozempic is available in the following dosages:

  • 0.25 mg
  • 0.5 mg
  • 1 mg
  • 2 mg

Before being increased to 0.5 mg each week, Ozempic is first started at an initial, non-therapeutic dose of 0.25 mg for four weeks. A doctor will assess whether or not additional dose increases are required, up to a maximum of 2 mg per week, four weeks after beginning the 0.5 mg dose. Ozempic’s dosage can be gradually increased over time to assist the body adapt to the new medication and can lessen negative effects.

What Exactly Is Rybelsus?

In 2019, the FDA approved the brand-name medicine Rybelsus (semaglutide) for the treatment of Type 2 Diabetes in individuals over the age of 18. Novo Nordisk is the manufacturer of it.


Rybelsus is an oral tablet that should be taken once a day. It must be taken in the morning with no more than 4 ounces on an empty stomach. 30 minutes before taking any other prescriptions or having breakfast, drink at least 8 glasses of water.

Rybelsus should be kept dry and at room temperature. It must not be mixed with other medications or put in a pill organizer, and it must be stored in its original bottle.


The doses for Rybelsus pills are as follows:

  • 3 mg
  • 7 mg
  • 14 mg

Typically, patients begin taking Rybelsus for 30 days at a dosage of 3 mg. They then increase the dosage to 7 mg for an additional 30 days. When such happens, a medical evaluation is helpful in deciding whether or not to increase the dosage to the maximum of 14 mg per day. By gradually raising Rybelsus dosage over time, one gives the body time to get used to the new drug and frequently lessens the overall severity of adverse effects. Understanding Ozempic benefits can also provide valuable insights for patients considering alternative treatments or complementary options.

What Are the Primary Distinctions Between Rybelsus and Ozempic?

Both Rybelsus and Ozempic, which are essentially different formulations of the same medication, contain the active component semaglutide. Their main differences are as follows:

  • Method of Delivery – Rybelsus is administered orally once daily as a pill, whereas Ozempic is administered subcutaneously once a week.
  • Dosage – The dosage ranges for Rybelsus and Ozempic is 3 mg to 14 mg per day and 0.25 to 2 mg per week, respectively.
  • Indication – individuals with Type 2 Diabetes and associated cardiovascular disease are treated with Ozempic; individuals with Type 2 Diabetes are treated with Rybelsus.

How Do Rybelsus and Ozempic Function?

The drugs Rybelsus and Ozempic are both categorized as GLP-1 receptor agonists. The hormone GLP-1, which is naturally produced in the human gut in response to eating, is mimicked by its active ingredient, semaglutide.

GLP-1 alerts different bodily systems that digestion is taking place. It lessens hunger, promotes the production of insulin from the pancreas, and lowers the quantity of glucose that is released into the bloodstream.

The effects of semaglutide are identical to those of its naturally occurring analog since both drugs attach to GLP-1 receptors in the body. By delaying gastric emptying and the digestive process, it aids in continuing blood sugar regulation, decreases hunger, and fosters feelings of satiety.

Both Rybelsus and Ozempic collaborate. The combination of both drugs with a balanced diet, regular exercise, and other lifestyle changes produces the best results.

Are Rybelsus and Ozempic equally efficient?

A two-part response is required for this question.

Yes, if all we’re talking about is lowering blood sugar levels in Type 2 Diabetes patients. Despite the fact that no direct head-to-head research trial comparing the two medications has been conducted, substantial clinical investigations of Ozempic and Rybelsus on their own have shown that both medications are equally effective for controlling blood sugar when used in conjunction with diet and exercise.

Despite this, studies have indicated that Ozempic can lower the risk of significant cardiovascular outcomes in patients with Type 2 Diabetes and heart disease, whilst Rybelsus has been demonstrated to be safe for patients with heart issues. Ozempic is the more effective medication in this regard.

Can Rybelsus and Ozempic Be Used to Lose Weight?

Semaglutide is frequently linked to weight reduction since it reduces hunger, slows down digestion, and frequently produces gastrointestinal problems. In fact, many Type 2 Diabetes patients say they may effortlessly lose weight while taking Rybelsus and Ozempic. These reports are supported by research.

Although neither Ozempic nor Rybelsus is specifically labeled for weight loss, a doctor may choose to give them for this purpose off-label.

In 2021 and 2022, the FDA authorized Novo Nordisk’s Wegovy, a third semaglutide medication, for the management of chronic weight in adults. Wegovy, an injectable medicine, has a greater maximum dose of semaglutide (2.4 mg), similar to Ozempic. Patients who are obese or overweight and have at least one weight-related medical problem should consider it.

Which Medicine Is More Effective for Weight Loss?

As previously stated, neither Rybelsus nor Ozempic are recommended for weight loss. Despite this, research indicates that patients tend to lose more weight when using Ozempic than when taking Rybelsus. Wegovy was eventually approved as a weight reduction medication thanks to Ozempic’s clinical weight loss trials.

Rybelsus and Ozempic Side Effects

Semaglutide is an ingredient in both Ozempic and Rybelsus, hence their potential side effects are extremely similar. Most adverse effects of both medications are minor and frequently go away with time.

Typical minor adverse effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Stomach discomfort
  • Adverse drug reaction (only with Ozempic)

Both Rybelsus and Ozempic may occasionally cause more severe adverse effects. If you encounter any of the following, consult your doctor right away or get medical attention right away:

  • Pancreatitis
  • Severe gallbladder illness
  • Severe hypoglycemia (low blood sugar)
  • Modifications in vision (Diabetic retinopathy)
  • Serious allergic responses
  • Severe renal issues

There is a black box warning on the packaging of both drugs addressing the potential growth of thyroid C-cell tumors. Although semaglutide has not been examined in people, animal trials on the drug have shown that thyroid cancers can develop. If you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia Type 2 (MENS2), it is not advised that you take Ozempic or Rybelsus.

If you are pregnant, nursing, or intend to become pregnant, you shouldn’t use Ozempic or Rybelsus.

General Questions

Do I require a prescription for Rybelsus and Ozempic?

Yes. Both Rybelsus and Ozempic are prescribed medications. Both of these require a prescription from your doctor in order to be purchased.

Can I take Rybelsus or Ozempic without having Type 2 Diabetes?

Only take Ozempic or Rybelsus as directed by your physician. Although both medications have a Type 2 Diabetes indication, they may be prescribed off-label for other conditions like weight control.

How long should I take Rybelsus or Ozempic?

Ozempic and Rybelsus are both long-term medications that can be taken for the rest of your life if issues don’t emerge from your type 2 diabetes, which is a chronic disease. Be advised that if you stop taking semaglutide after being prescribed either medication off-label for chronic weight management, you’ll probably gain back most of the weight you lost.

How much are Rybelsus and Ozempic?

The usual cost of an Ozempic pen (generally one month’s supply) in the US is between roughly $800 and $1300, though costs vary from pharmacy to pharmacy and state to state.

One month’s worth of Rybelsus typically costs between $800 and $1,000 for 30 tablets.

Costs could be significantly cheaper if you have insurance that covers these medicines. For the treatment of Type 2 Diabetes, the majority of insurance companies do cover Ozempic and Rybelsus, although many do not cover them for off-label uses.

The Bottom Line

In conclusion, Novo Nordisk’s semaglutide-based medications Rybelsus and Ozempic are both prescribed for decreasing blood sugar levels in adult patients with Type 2 Diabetes. Along with this, Ozempic aids patients with Type 2 Diabetes and heart disease in reducing their risk of serious cardiovascular events.

Rybelsus is an oral drug used once a day in tablet form, whereas Ozempic is an injectable treatment taken once a week. Although neither medication has been licensed for weight management, both have been linked to healthy weight loss when combined with dietary and activity modifications and other lifestyle changes. The FDA has approved Wegovy, an injectable semaglutide drug at a dose slightly higher than Ozempic, for chronic weight management in obese and overweight people.

Make the wise choice for your health journey – with Better You Rx Pharmacy, you’re not just buying medication; you’re investing in a healthier future. Consult with our dedicated healthcare professionals today to discover the perfect solution for your Type 2 Diabetes management and weight loss goals.

Unlock the power of medical expertise and convenience at Better You Rx Pharmacy. Start your journey towards better health and improved well-being with the medications you need. Your prescription is our mission – order now and experience the Better You difference.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up For Newsletter

Join 60.000+ Subscribers and get a new discount coupon on every Saturday.


PO Box 29631, Mississauga RPO Central Parkway, ON L5A 4H2

Contact Us



Welcome to Better youRx, where your well-being is our top priority. We are a leading pharmacy, committed to providing you with a wide range of medications, including insulin and diabetes supplies, along with an array of essential healthcare products. Our mission is to empower you on your journey to better health by offering high-quality pharmaceuticals and exceptional customer care.

Our Payment Partners :

Copyright © 2023 BetteryouRX. All Rights Reserved.

Add to cart